Extending the benefits of indicated prevention to improve outcomes of first-episode psychosis

JAMA Psychiatry

Volumn 74, Issue 7, 2017, Pages 667-668

  Fusar Poli, Paolo ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HELP SEEKING BEHAVIOR; HUMAN; MENTAL HEALTH CARE; MENTAL HEALTH SERVICE; NOTE; OUTCOME ASSESSMENT; PATIENT REFERRAL; PRIMARY MEDICAL CARE; PRIMARY PREVENTION; PROPHYLAXIS; PSYCHOSIS; SECONDARY HEALTH CARE; SECONDARY PREVENTION; SOCIAL MEDIA; EARLY DIAGNOSIS; EARLY INTERVENTION; FORECASTING; MASS SCREENING; PSYCHOLOGY; RISK ASSESSMENT; RISK FACTOR; TRENDS; UNITED KINGDOM;

EARLY DIAGNOSIS; EARLY MEDICAL INTERVENTION; FORECASTING; HUMANS; MASS SCREENING; PRIMARY PREVENTION; PSYCHOTIC DISORDERS; REFERRAL AND CONSULTATION; RISK ASSESSMENT; RISK FACTORS; UNITED KINGDOM;

EID: 85024095250     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2017.1009     Document Type: Note

References (9)

1. Fusar-Poli P, Díaz-Caneja CM, Patel R, et al. Services for people at high risk improve outcomes in patients with first episode psychosis. Acta Psychiatr Scand. 2016;133(1):76-85
2. Fusar-Poli P, Rutigliano G, Stahl D, et al. Development and validation of a clinically based risk calculator for the transdiagnostic prediction of psychosis [published online March 29, 2017]. JAMA Psychiatry. doi: 10.1001/jamapsychiatry.2017.0284
3. Fusar-Poli P, Schultze-Lutter F, Cappucciati M, et al. The dark side of the moon: meta-analytical impact of recruitment strategies on risk enrichment in the clinical high risk state for psychosis. Schizophr Bull. 2016;42(3):732-743
4. Fusar-Poli P, Rutigliano G, Stahl D, et al. Deconstructing pretest risk enrichment to optimize prediction of psychosis in individuals at clinical high risk. JAMA Psychiatry. 2016;73(12):1260-1267
5. Fusar-Poli P, Tantardini M, De Simone S, et al. Deconstructing vulnerability for psychosis: meta-analysis of environmental risk factors for psychosis in subjects at ultra high-risk. Eur Psychiatry.2017;40:65-75
6. Schultze-Lutter F, Michel C, Schmidt SJ, et al. EPA guidance on the early detection of clinical high risk states of psychoses. Eur Psychiatry. 2015;30(3): 405-416
7. Perez J, Jin H, Russo DA, et al. Clinical effectiveness and cost-effectiveness of tailored intensive liaison between primary and secondary care to identify individuals at risk of a first psychotic illness (the LEGs study): a cluster-randomised controlled trial. Lancet Psychiatry. 2015;2(11): 984-993
8. Calkins ME, Moore TM, Satterthwaite TD, et al. Persistence of psychosis spectrum symptoms in the Philadelphia Neurodevelopmental Cohort: a prospective two-year follow-up. World Psychiatry.2017;16(1):62-76
9. Fusar-Poli P. Negative psychosis prevention trials [published online April 12, 2017]. JAMA Psychiatry.doi: 10.1001/jamapsychiatry.2017.0185